James T. Wasicak

1.2k citations

20 papers · 937 indexed · h-index 14

Co-authors: Mark W. Holladay Stephen P. Arnerić David S. Garvey Diana L. Donnelly‐Roberts Nan‐Horng Lin Michael Williams James P. Sullivan John Y. L. Chung
Topics: Cholinesterase and Neurodegenerative Diseases (10 papers)Nicotinic Acetylcholine Receptors Study (10 papers)Chemical synthesis and alkaloids (6 papers)
Cited by: Pharmacology Organic Chemistry Molecular Biology
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics The Journal of Organic Chemistry
Partner nations: United States United Kingdom Germany

In The Last Decade

James T. Wasicak

20 papers receiving 899 citations

Peers

Countries citing papers authored by James T. Wasicak

Since Specialization

Citations

This map shows the geographic impact of James T. Wasicak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Wasicak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Wasicak more than expected).

Fields of papers citing papers by James T. Wasicak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. Wasicak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Wasicak. The network helps show where James T. Wasicak may publish in the future.

Co-authorship network of co-authors of James T. Wasicak

This figure shows the co-authorship network connecting the top 25 collaborators of James T. Wasicak. A scholar is included among the top collaborators of James T. Wasicak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Wasicak. James T. Wasicak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural aspects of high affinity ligands for the α4β2 neuronal nicotinic receptor 2000 ·Pharmaceutica Acta Helvetiae ·Michael J. Dart,James T. Wasicak,Keith B. Ryther,Michael R. Schrimpf,Ki H. Kim,David J. Anderson,James P. Sullivan,Michael D. Meyer	29
2	Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework 1999 ·Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin,(unknown),David Gunn,Suzanne A. Lebold,Edmund Lee,James T. Wasicak,(unknown),Jerome F. Daanen,David S. Garvey,Jeffrey E. Campbell,(unknown),Michael T. Williams,Stephen P. Arnerić	12
3	Discovery of a Series of Cyclohexylethylamine-Containing Protein Farnesyltransferase Inhibitors Exhibiting Potent Cellular Activity 1999 ·Journal of Medicinal Chemistry ·Kenneth J. Henry,James T. Wasicak,Andrew S. Tasker,Jerome Cohen,(unknown),Michael J. Mitten,(unknown),Douglas Kalvin,Rolf E. Swenson,Shi‐Chung Ng,(unknown),Sajeev Cherian,Hing L. Sham,Saul H. Rosenberg	17
4	ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A Novel, Orally Effective Antinociceptive Agent Acting via Neuronal Nicotinic Acetylcholine Receptors: II. In Vivo Characterization 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Anthony W. Bannon,Michael Decker,Peter Curzon,Michael Buckley,David J.B. Kim,Richard J. Radek,J.A. Lynch,James T. Wasicak,Nan‐Horng Lin,William H. Arnold,Mark W. Holladay,Michael Williams,Stephen P. Arnerić	61
5	ABT-594 [(R)-5-(2-Azetidinylmethoxy)-2-Chloropyridine]: A Novel, Orally Effective Analgesic Acting via Neuronal Nicotinic Acetylcholine Receptors: I. In Vitro Characterization 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Diana L. Donnelly‐Roberts,Pamela S. Puttfarcken,Theresa A. Kuntzweiler,(unknown),David J. Anderson,Jeffrey E. Campbell,Marietta Piattoni-Kaplan,David G. McKenna,James T. Wasicak,Mark W. Holladay,Michael T. Williams,Stephen P. Arnerić	79
6	Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 3. Discovery of a Potent, 2-Nonaryl, Highly Selective ET_A Antagonist (A-216546) 1998 ·Journal of Medicinal Chemistry ·Gang Liu,Kenneth J. Henry,Bruce G. Szczepankiewicz,Martin Winn,(unknown),Steven A. Boyd,James T. Wasicak,Thomas W von Geldern,Jinshyun R. Wu‐Wong,William J. Chiou,Douglas B. Dixon,Bach Nguyen,Kennan C. Marsh,Terry J. Opgenorth	17
7	Identification and Initial Structure−Activity Relationships of (R)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors 1998 ·Journal of Medicinal Chemistry ·Mark W. Holladay,James T. Wasicak,Nan‐Horng Lin,Yun He,Keith B. Ryther,Anthony W. Bannon,Michael Buckley,David J.B. Kim,Michael Decker,David J. Anderson,Jeffrey E. Campbell,Theresa A. Kuntzweiler,Diana L. Donnelly‐Roberts,Marietta Piattoni-Kaplan,Clark A. Briggs,Michael Williams,Stephen P. Arnerić	111
8	Studies on the preparation of protomycinolide IV: Enantioselective synthesis of the C3–C9 segment 1998 ·Tetrahedron Asymmetry ·James T. Wasicak,William A. Donaldson	1
9	Alkylation of tricarbonyl(diene)iron complexes: Model studies for the preparation of protomycinolide IV 1997 ·Tetrahedron ·James T. Wasicak,(unknown),(unknown),(unknown),Huameng Li,William A. Donaldson	14
10	A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In Vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand 1996 ·Neuropharmacology ·(unknown),Diana L. Donnelly‐Roberts,(unknown),David J. Anderson,Murali Gopalakrishnan,Marietta Piattoni-Kaplan,Jeffrey E. Campbell,David G. McKenna,(unknown),(unknown),David S. Garvey,James T. Wasicak,Mark W. Holladay,Michael T. Williams,Stephen P. Arnerić	121
11	ChemInform Abstract: Novel 3‐Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors (nAChR′s). 1996 ·ChemInform ·(unknown),(unknown),David S. Garvey,David Gunn,(unknown),James T. Wasicak,(unknown),Yvonne C. Martin,Diana L. Donnelly‐Roberts,David J. Anderson,James P. Sullivan,Michael T. Williams,Stephen P. Arnerić,Mark W. Holladay	8
12	Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors 1996 ·Journal of Medicinal Chemistry ·(unknown),Nan‐Horng Lin,David S. Garvey,David Gunn,(unknown),James T. Wasicak,(unknown),Yvonne C. Martin,Diana L. Donnelly‐Roberts,David J. Anderson,James P. Sullivan,Michael Williams,Stephen P. Arnerić,Mark W. Holladay	199
13	Characterization of [3H]ABT-418: a novel cholinergic channel ligand. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·David J. Anderson,M. Williams,(unknown),J L Raszkiewicz,Jeffrey E. Campbell,(unknown),Bruce W. Surber,(unknown),James T. Wasicak,Stephen P. Arnerić	28
14	Ligands for Brain Cholinergic Channel Receptors: Synthesis and in Vitro Characterization of Novel Isoxazoles and Isothiazoles as Bioisosteric Replacements for the Pyridine Ring in Nicotine 1994 ·Journal of Medicinal Chemistry ·David S. Garvey,James T. Wasicak,Richard L. Elliott,Suzanne A. Lebold,(unknown),George M. Carrera,Nan‐Horng Lin,(unknown),Mark W. Holladay	51
15	Novel Isoxazoles which Interact with Brain Cholinergic Channel Receptors Have Intrinsic Cognitive Enhancing and Anxiolytic Activities 1994 ·Journal of Medicinal Chemistry ·David S. Garvey,James T. Wasicak,Michael Decker,Jorge D. Brioni,Michael Buckley,James P. Sullivan,George M. Carrera,Mark W. Holladay,Stephen P. Arnerić,Michael Williams	73
16	Synthesis and structure-activity relationships of pyrrolidine-modified analogs of the potent cholinergic channel activator, ABT 418 1994 ·Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin,Yun He,(unknown),James T. Wasicak,(unknown),David J. Sweeny,(unknown)	8
17	Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors 1992 ·Journal of Medicinal Chemistry ·David S. Garvey,James T. Wasicak,John Y. L. Chung,(unknown),George M. Carrera,Paul D. May,(unknown),David J. Anderson,(unknown)	12
18	Conformationally Constrained Amino Acids.¹on the Synthesis of 4-Substituted 8-Membered Cyclic Tryptophan Derivatives 1992 ·Synthetic Communications ·John Y. L. Chung,James T. Wasicak,Alex M. Nadzan	11
19	Conformationally constrained amino acids. Synthesis and optical resolution of 3-substituted proline derivatives 1990 ·The Journal of Organic Chemistry ·John Y. L. Chung,James T. Wasicak,William A. Arnold,(unknown),Alex M. Nadzan,Mark W. Holladay	67
20	Synthesis of chiral α-acetylenic cyclic amines from α-amino acids: Applications to differentially constrained oxotremorine analogues as muscarinic agents 1990 ·Tetrahedron Letters ·John Y. L. Chung,James T. Wasicak	18

About James T. Wasicak

James T. Wasicak is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology, having authored 20 papers that have together received 937 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (10 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Chemical synthesis and alkaloids (6 papers). The work is most often cited by research in Pharmacology (251 citations), Organic Chemistry (401 citations) and Molecular Biology (754 citations). James T. Wasicak has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Mark W. Holladay, Stephen P. Arnerić, David S. Garvey, Diana L. Donnelly‐Roberts, Nan‐Horng Lin, Michael Williams, James P. Sullivan, John Y. L. Chung, Jeffrey E. Campbell and David J. Anderson. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact